Skip to main content
Top
Published in: BMC Infectious Diseases 1/2008

Open Access 01-12-2008 | Research article

Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)

Authors: Silvio Tafuri, Rosa Prato, Domenico Martinelli, Agata Calvario, Anna Bozzi, Michele Labianca, Annamaria Patti, Pietro Luigi Lopalco, Cinzia Germinario

Published in: BMC Infectious Diseases | Issue 1/2008

Login to get access

Abstract

Background

In 1988 the World Health Assembly adopted the goal to eradicate poliomyelitis by routine immunization using Oral Polio Vaccine (OPV). On 21 June 2002 the WHO European Region was declared polio-free. In 2008 poliomyelitis is still endemic in 4 countries (Nigeria, India, Pakistan, and Afghanistan), where 1201 new cases were registered in 2007; 107 sporadic cases were also notified in countries where poliovirus is not endemic. The aim of this work was to verify the level of antipoliomyelitis immunity status in children and adolescents in the Apulia region (south of Italy), which may be considered a border region due to its position.

Methods

704 blood specimens from a convenience sample were collected in six laboratories. The age of subjects enrolled was 0–15 years. The immunity against poliomyelitis was evaluated by neutralizing antibody titration in tissue culture microplates.

Results

Seropositivity (neutralising antibodies titre ≥ 8) for polioviruses 1, 2 and 3 was detected in 100%, 99.8% and 99.4% of collected sera. Antibody titres were not lower in subjects who received either four doses of inactivated polio vaccine (IPV) or a sequential schedule consisting of two doses of IPV and two of oral polio vaccine than in subjects who received four doses of OPV.

Conclusion

These results confirmed current data of vaccine coverage for poliomyelitis: during the last ten years in Apulia, the coverage in 24 months old children was more than 90%. The high level of immunization found confirms the effectiveness both of the sequential schedule IPV-OPV and of the schedule all-IPV. Apulia region has to face daily arrivals of refugees and remains subject to the risk of the importation of poliovirus from endemic areas. Surveys aimed at determining anti-polio immunity in subpopulations as well as in the general population should be carried out.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Assembly GSWHO: Global Eradication of Poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. 1988, Geneva (Switzerland): World Health Organization, (Resolution WHA4128) World Health Assembly GSWHO: Global Eradication of Poliomyelitis by the year 2000: resolution of the 41st World Health Assembly. 1988, Geneva (Switzerland): World Health Organization, (Resolution WHA4128)
2.
go back to reference Birmingham ME, Aylward RB, Cochi SL, Hull HF: National immunization days: state of the art. J Infect Dis. 1997, 175 (1): 183-188.CrossRef Birmingham ME, Aylward RB, Cochi SL, Hull HF: National immunization days: state of the art. J Infect Dis. 1997, 175 (1): 183-188.CrossRef
3.
go back to reference De Quardos CA, Andrus JK, Olive JM, Carrasco P: Strategies for poliomyelitis eradication in developing countries. Public Health Rev. 1994, 21 (1–2): 65-78. De Quardos CA, Andrus JK, Olive JM, Carrasco P: Strategies for poliomyelitis eradication in developing countries. Public Health Rev. 1994, 21 (1–2): 65-78.
4.
go back to reference Oblapenko G: Poliomyelitis eradication in Europe: programme and activities. Public Health Rev. 1994, 21 (1–2): 117-127. Oblapenko G: Poliomyelitis eradication in Europe: programme and activities. Public Health Rev. 1994, 21 (1–2): 117-127.
5.
go back to reference Wassilak SG, Oblapenko GP, Dittmann S, Aylward RB, Hull HF: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016/S0140-6736(05)65063-5.CrossRefPubMed Wassilak SG, Oblapenko GP, Dittmann S, Aylward RB, Hull HF: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016/S0140-6736(05)65063-5.CrossRefPubMed
6.
go back to reference Oblapenko G, Sutter RW: Status of poliomyelitis eradication in Europe and the Central Asia Republics fo the Former Soviet Union. J Infect Dis. 1997, 175 (Suppl 1): 76-81.CrossRef Oblapenko G, Sutter RW: Status of poliomyelitis eradication in Europe and the Central Asia Republics fo the Former Soviet Union. J Infect Dis. 1997, 175 (Suppl 1): 76-81.CrossRef
7.
go back to reference Borgono JM: International Committee for the Certification of Poliomyelitis Eradication (letter). Rev Med Chil. 1993, 121 (12): 1445-PubMed Borgono JM: International Committee for the Certification of Poliomyelitis Eradication (letter). Rev Med Chil. 1993, 121 (12): 1445-PubMed
8.
go back to reference WHO, Geneva: Expanded Programme on Immunization (EPI). Poliomyelitis eradication. Wkly Epidemiol Rec. 1994, 69 (7): 45-7. WHO, Geneva: Expanded Programme on Immunization (EPI). Poliomyelitis eradication. Wkly Epidemiol Rec. 1994, 69 (7): 45-7.
9.
go back to reference Greco D, Fiore L, Sallabanda A, Diamanti H: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016/S0140-6736(97)80066-9.CrossRefPubMed Greco D, Fiore L, Sallabanda A, Diamanti H: Poliomyelitis vaccination strategies for Europe. Lancet. 1997, 349: 437-10.1016/S0140-6736(97)80066-9.CrossRefPubMed
11.
go back to reference WHO: Global polio eradication initiative strategic plan 2004–2008. 2004, Geneva:WHO WHO: Global polio eradication initiative strategic plan 2004–2008. 2004, Geneva:WHO
12.
13.
go back to reference Plotkin SA, Vidor E: Poliovirus vaccine-inactivated. Vaccines. Edited by: Plotkin SA, Orenstein WA. 2004, Philadelphia: Saunders, 625-49. 4 Plotkin SA, Vidor E: Poliovirus vaccine-inactivated. Vaccines. Edited by: Plotkin SA, Orenstein WA. 2004, Philadelphia: Saunders, 625-49. 4
14.
go back to reference Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, et al: Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Sciente. 2002, 296: 356-9. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, et al: Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Sciente. 2002, 296: 356-9.
15.
go back to reference Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al: Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004, 78: 13512-21. 10.1128/JVI.78.24.13512-13521.2004.CrossRefPubMedPubMedCentral Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al: Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004, 78: 13512-21. 10.1128/JVI.78.24.13512-13521.2004.CrossRefPubMedPubMedCentral
16.
go back to reference Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Balanant J, Delpeyroux F: Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis. 2003, 9: 885-7.CrossRefPubMedPubMedCentral Rousset D, Rakoto-Andrianarivelo M, Razafindratsimandresy R, Balanant J, Delpeyroux F: Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis. 2003, 9: 885-7.CrossRefPubMedPubMedCentral
17.
go back to reference Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al: Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003, 77: 8366-77. 10.1128/JVI.77.15.8366-8377.2003.CrossRefPubMedPubMedCentral Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al: Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003, 77: 8366-77. 10.1128/JVI.77.15.8366-8377.2003.CrossRefPubMedPubMedCentral
18.
go back to reference Center for Disease Control and Prevention: Poliovirus Infections in four unvaccinated children-Minnesota August-October 2005. MMWR Morb Moral Wkly Rep. 2005, 54: 1053-5. Center for Disease Control and Prevention: Poliovirus Infections in four unvaccinated children-Minnesota August-October 2005. MMWR Morb Moral Wkly Rep. 2005, 54: 1053-5.
19.
go back to reference Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine using countries. Wkly Epidemiol Rec. 78 (28): 241-50. 2003 Jul 11 Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine using countries. Wkly Epidemiol Rec. 78 (28): 241-50. 2003 Jul 11
20.
go back to reference Alexander LN, Steward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, et al: Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 292 (14): 1696-701. 10.1001/jama.292.14.1696. 2004 Oct 12 Alexander LN, Steward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, et al: Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA. 292 (14): 1696-701. 10.1001/jama.292.14.1696. 2004 Oct 12
21.
go back to reference Ministero della Salute, Italia: Circolare n 5. 7 April 1999 Ministero della Salute, Italia: Circolare n 5. 7 April 1999
22.
go back to reference Conferenza permanente per i rapporti tra lo Stato, le Regioni e le Province Autonome di Trento e Bolzano, 30 may. 2002, . Accordo tra il Ministero della Salute, le Regioni e le Province Autonome di Trento e Bolzano sulle modifiche al calendario della vaccinazione anti-poliomielitica Conferenza permanente per i rapporti tra lo Stato, le Regioni e le Province Autonome di Trento e Bolzano, 30 may. 2002, . Accordo tra il Ministero della Salute, le Regioni e le Province Autonome di Trento e Bolzano sulle modifiche al calendario della vaccinazione anti-poliomielitica
23.
go back to reference Ministero della Salute, Italia, Piano Nazionale Vaccini 2005-Gazzetta Ufficiale Repubblica Italiana, Suppl. Ordinario,14 april 2005. 2007 Ministero della Salute, Italia, Piano Nazionale Vaccini 2005-Gazzetta Ufficiale Repubblica Italiana, Suppl. Ordinario,14 april 2005. 2007
24.
go back to reference Gaudelus J, Ovetichkine P, Cheymol J, De Courson F, Allaert FA: Compliance with the vaccination recommendations for o- to 24-month-old infants in general or paediatric pratice. Arch Pediatr. 2003, 10 (9): 781-6. 10.1016/S0929-693X(03)00409-3.CrossRefPubMed Gaudelus J, Ovetichkine P, Cheymol J, De Courson F, Allaert FA: Compliance with the vaccination recommendations for o- to 24-month-old infants in general or paediatric pratice. Arch Pediatr. 2003, 10 (9): 781-6. 10.1016/S0929-693X(03)00409-3.CrossRefPubMed
26.
go back to reference Mastroeni I, Patti AM, Fabrizi A, Santi AL, Manduca AM, Vescia N, et al: Immunity status against poliomyelitis in persons 13–14 years old living in Rome. Vaccine. 1997, 15 (6/7): 747-50. 10.1016/S0264-410X(96)00208-3.CrossRefPubMed Mastroeni I, Patti AM, Fabrizi A, Santi AL, Manduca AM, Vescia N, et al: Immunity status against poliomyelitis in persons 13–14 years old living in Rome. Vaccine. 1997, 15 (6/7): 747-50. 10.1016/S0264-410X(96)00208-3.CrossRefPubMed
27.
go back to reference Pianetti A, Salvaggio L, Biffi MR, Baffone W, Bruscolini F, de Donato S, Albano A: Antipoliomyelitis immunity status in cohort of young men drafted into military service, residing in the suburban Milan area. Eur J Epidemiol. 1997, 13: 725-27. 10.1023/A:1007331900645.CrossRefPubMed Pianetti A, Salvaggio L, Biffi MR, Baffone W, Bruscolini F, de Donato S, Albano A: Antipoliomyelitis immunity status in cohort of young men drafted into military service, residing in the suburban Milan area. Eur J Epidemiol. 1997, 13: 725-27. 10.1023/A:1007331900645.CrossRefPubMed
28.
go back to reference Lopalco PL, Germinario C, Calvario A, Chironna M, Quarto M, Barbuti S: High level of immunity against Poliomyelitis in Albanian refugees in Southern Italy. J Travel Med. 2000, 7: 111-115.CrossRefPubMed Lopalco PL, Germinario C, Calvario A, Chironna M, Quarto M, Barbuti S: High level of immunity against Poliomyelitis in Albanian refugees in Southern Italy. J Travel Med. 2000, 7: 111-115.CrossRefPubMed
29.
go back to reference Prato R, Labianca M, Calvario A, Bozzi A, Rizzo C, Fiore L, et al: Evaluation of the Surveillance System of Acute Flaccid Paralysis in Puglia: 5 years of work. Ann Ig. 2002, 14 (6): 487-94.PubMed Prato R, Labianca M, Calvario A, Bozzi A, Rizzo C, Fiore L, et al: Evaluation of the Surveillance System of Acute Flaccid Paralysis in Puglia: 5 years of work. Ann Ig. 2002, 14 (6): 487-94.PubMed
30.
go back to reference WHO: Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis. 1990, Geneva; WHO, 44-65. WHO: Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis. 1990, Geneva; WHO, 44-65.
31.
go back to reference Patti AM, Santi AL, Bellucci C, Ciappetti C, Fara GM, Germinario C, et al: Serological survey on immunità status againist polioviruses in Italian young adults and in immigrants. Ann Ig. 1999, 11: 353-359.PubMed Patti AM, Santi AL, Bellucci C, Ciappetti C, Fara GM, Germinario C, et al: Serological survey on immunità status againist polioviruses in Italian young adults and in immigrants. Ann Ig. 1999, 11: 353-359.PubMed
32.
go back to reference Stagni G, Merletti L, De Rosa F: Livelli di anticorpi specifici per i virus poliomielitici e grado di protezione immunitaria nella popolazione umbra. Boll Ist Sieroter Milan. 1979, 58: 210-15.PubMed Stagni G, Merletti L, De Rosa F: Livelli di anticorpi specifici per i virus poliomielitici e grado di protezione immunitaria nella popolazione umbra. Boll Ist Sieroter Milan. 1979, 58: 210-15.PubMed
33.
go back to reference Volpi A, Ragona G, Biondi W, Rocchi G, Archetti I: Seroimmunity to polioviruses in an urban population of Italy. Wld Htl Org Bull. 1976, 54: 275-78. Volpi A, Ragona G, Biondi W, Rocchi G, Archetti I: Seroimmunity to polioviruses in an urban population of Italy. Wld Htl Org Bull. 1976, 54: 275-78.
34.
go back to reference Majori S, Baldo V, Poli A, Riolfatti M, Alborino F, Bonello C, et al: Immunity to poliovirus among children and the elderly in north-east Italy. J Prev Med and Hyg. 2006, 47: 12-15. Majori S, Baldo V, Poli A, Riolfatti M, Alborino F, Bonello C, et al: Immunity to poliovirus among children and the elderly in north-east Italy. J Prev Med and Hyg. 2006, 47: 12-15.
35.
go back to reference Fine PE, Oblapenko G, Sutter RW: Polio control after certification: major issues outstanding. Bull World Health Organ. 2004, 82 (1): 47-52. Epub 2004 Feb 26PubMedPubMedCentral Fine PE, Oblapenko G, Sutter RW: Polio control after certification: major issues outstanding. Bull World Health Organ. 2004, 82 (1): 47-52. Epub 2004 Feb 26PubMedPubMedCentral
Metadata
Title
Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy)
Authors
Silvio Tafuri
Rosa Prato
Domenico Martinelli
Agata Calvario
Anna Bozzi
Michele Labianca
Annamaria Patti
Pietro Luigi Lopalco
Cinzia Germinario
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2008
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-8-150

Other articles of this Issue 1/2008

BMC Infectious Diseases 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.